Skip to main content

Advertisement

Table 4 Univariate and multivariate analysis of clinical variables affecting 5-year survival of lung cancer patients, including our classifier, with hazard ratios (HR).

From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

Clinical variable Comparison p-value (univariate) p-value (multivariate) HR
T stage T1-2 vs. T3-4 1 × 10 -7 1.77 × 10 -5 2.6
N stage Nodes uninvolved (N0) vs. Nodes involved (N1-2) 2.84 × 10 -12 2.29 × 10 -11 2.8
Tumor grade Low grade (1) vs. intermediate or high grade (2-3) 0.12 0.37 1.3
Our classifier (MAPS) MAPS- vs. MAPS+ (Expressor) 4.66 × 10 -6 0.0001 1.8
  1. Statistically significant results are bolded.